Download PDF
Klin Monbl Augenheilkd 2023; 240(04): 566-568
DOI: 10.1055/a-2004-5504
Der interessante Fall

When Your Patient Needs New Glasses Every Day

Wenn die Patientin jeden Tag eine neue Brille benötigt
Dominique Prétot
1   Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland
,
Katrin Marie Engesser
1   Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland
,
Torsten Schlote
1   Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland
2   Ophthalmology, Ambimed Eye Clinic, Basel, Switzerland
,
Maria Della Volpe
1   Ophthalmology, Heuberger Eye Clinic AG, Olten, Switzerland
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Background

Inflammatory eye diseases have numerous etiologies. Here, we report on a rare case of intermittent bilateral myopic shifts in a healthy, young patient with initially no clinical manifestation of the underlying inflammatory cause.



Publication History

Received: 14 October 2022

Accepted: 21 December 2022

Article published online:
25 April 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1978; 22: 9-35
    PubMedSearch in Google Scholar
  • 2 Feldman BH, OʼKeefe GD, Salcedo HR. et al. Vogt-Koyanagi-Harada Disease. Accessed September 27, 2022 at: http://eyewiki.aao.org
    PubMed
  • 3 Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2021; 228: 205-211
    CrossrefPubMedSearch in Google Scholar
  • 4 Rao NA, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol 2007; 27: 195-199
    CrossrefPubMedSearch in Google Scholar
  • 5 Rathiam SR, Vijayalakshmi P, Namperumalsamy P. et al. Vogt–Koyanagi–Harada syndrome in children. Ocul Immunol Inflam 1998; 6: 155-161
    CrossrefPubMedSearch in Google Scholar
  • 6 Paredes I, Ahmed M, Foster C. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
    PubMedSearch in Google Scholar
  • 7 Lai TYY, Chan RPS, Chan CKM. et al. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 2009; 23: 543-548
    CrossrefPubMedSearch in Google Scholar
  • 8 Biswas J, Rao NA. Management of Intraocular Inflammation. In: Ryan SJ. ed. Retina. Vol. 2. St. Louis: Mosby-Year Book; 1994: 1061-1069
    Search in Google Scholar
  • 9 Rao NA, Blackman HJ, Franklin RM. et al. Intraocular Inflammation and Uveitis. In: Course Book. Basic and Clinical Science Course 1998 – 1999. San Francisco: American Academy of Ophthalmology; 1998: 76-79
    Search in Google Scholar
  • 10 Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87-90
    CrossrefPubMedSearch in Google Scholar
  • 11 Yang P, Wang H, Zhou H. et al. [Therapeutic regimen in Vogt Koyanagi Harada syndrome]. Zhonghua Yan Ke Za Zhi 2002; 38: 196-199
    PubMedSearch in Google Scholar